A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer (Q28203323)
Jump to navigation
Jump to search
scientific article (publication date: May 2003)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer |
scientific article (publication date: May 2003) |
Statements
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer (English)
0 references
May 2003
0 references
9
0 references
5
0 references
1639-47
0 references